NCT02241252View on ClinicalTrials.gov

Using an iPhone ECG to Monitor the QT Interval on Dofetilide and Sotalol Patients

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Cardiac ArrhythmiaQt Interval, Variation in
Interventions
DEVICE

iPhone ECG

Please see detailed description for additional information.

Trial Locations (1)

73104

University of Oklahoma Health Sciences Center, Oklahoma City

All Listed Sponsors
lead

University of Oklahoma

OTHER

NCT02241252 - Using an iPhone ECG to Monitor the QT Interval on Dofetilide and Sotalol Patients | Biotech Hunter | Biotech Hunter